Internal Medicine
RSSArticles
-
Prednisone vs. Placebo in Short-Term Prevention of Episodic Cluster Headaches
Prednisone, given at 100 mg for five days and then tapering by 20 mg every three days, is a safe and effective short-term prevention for episodic cluster headaches while waiting for longer-acting preventive agents to be initiated.
-
Cognitive Benefit of Rivastigmine in Parkinson’s Disease Dementia with Orthostatic Hypotension
Individuals with Parkinson’s disease dementia and orthostatic hypotension (OH) have more robust cognitive improvement from rivastigmine compared to those without OH. This greater response possibly is mediated by the anti-OH effect of rivastigmine.
-
Deficits in Neurotransmitters and Behavioral Disturbances in Frontotemporal Lobar Degeneration
In subjects with a syndrome associated with frontotemporal lobar degeneration, gamma aminobutyric acid and glutamate deficiency in the right inferior frontal gyrus was associated with greater degrees of impulsivity.
-
Focused Ultrasound in Parkinson’s Disease: Going Beyond Tremor
In this randomized controlled trial, patients with asymmetric Parkinson’s disease were assigned to noninvasive, focused ultrasound-mediated subthalamotomy or sham procedure. The authors reported improved motor function in the focused ultrasound group, with adverse events including weakness, dyskinesia, and gait disturbances.
-
Time-Restricted Eating, Weight Loss, and Metabolism
A randomized clinical trial comparing time-restricted eating with a 16-hour fasting interval to a structured three-meal-per-day control group resulted in equivalent weight loss in both groups and no reduction in metabolic markers in either group.
-
From Childhood to Adolescence: Metabolic Disturbance Risk Factors
An innovative statistical model examining the development of metabolic disturbances in a large sample of youths finds that having media in a bedroom (associated with higher risk) and belonging to a sports club (associated with lower risk) are among the modifiable risk factors in this population.
-
Pharmacogenetics in Primary Care: An Update
Advancements in the area of personalized medicine and understanding how one’s genetics affect health outcomes is an evolving science. The addition of pharmacogenetic testing to the armamentarium of primary care providers presents an opportunity to improve patient care.
-
Infectious Disease Alert Updates
Excess Deaths During COVID-19; Subclinical Influenza Infection in Healthcare Workers; Compression Garments Effective in Reducing Cellulitis
-
Neurotropism of COVID-19: What Is New?
SARS-CoV-2 may gain access to the brain via the olfactory epithelium. The olfactory epithelium and bulbs may serve as an entry point for SARS-CoV-2 infection into the central nervous system.
-
Does the Addition of IV Metronidazole Improve Outcomes of Severe Clostridioides difficile Infection?
These studies indicate that the addition of intravenously administered metronidazole in the treatment of severe Clostridioides difficile infection is unwarranted.